ALD (Adrenoleukodystrophy): Clinical Trials

4 trials for ALD (Adrenoleukodystrophy), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1

Follow ALD (Adrenoleukodystrophy): new trials by email Literature Review of ALD (Adrenoleukodystrophy) trials Research Report on ALD (Adrenoleukodystrophy)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess PXL065 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD)
PXL065 - ALD (Adrenoleukodystrophy)
Phase 2WithdrawnPoxel SA2023-09-012024-12-16
Adrenoleukodystrophy National Registry Study
Medical Record Abstraction, Biospecimen Sample Collection - ALD (Adrenoleukodystrophy), Adrenoleukodystrophy
RecruitingMasonic Cancer Center, University of Minnesota10002019-05-012026-05-12
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
Leukodystrophy, White Matter Disease
CompletedChildren's Hospital of Philadelphia2362017-01-062025-11-10
The Myelin Disorders Biorepository Project
Leukodystrophy, White Matter Disease
RecruitingChildren's Hospital of Philadelphia120002016-12-082025-10-23

Narrower conditions

Adrenoleukodystrophy (4)  ·  Aicardi-Goutieres syndrome (2)  ·  Alexander Disease (2)  ·  Alexanders leukodystrophy (2)  ·  Allan-Herndon-Dudley syndrome (2)  ·  Attention Deficit Disorder with Hyperactivity (2)  ·  CADASIL (2)  ·  Canavan Disease (2)  ·  Charcot-Marie-Tooth Disease (2)  ·  Cockayne Syndrome (2)  ·  Gangliosidoses (2)  ·  Gangliosidoses, GM2 (2)  ·  Leukodystrophy, Globoid Cell (2)  ·  Leukodystrophy, Hypomyelinating, 5 (2)  ·  Leukodystrophy, Hypomyelinating, 6 (2)

Broader conditions

Adrenal Gland Diseases (4)  ·  Adrenal Insufficiency (4)  ·  Brain Diseases (4)  ·  Brain Diseases, Metabolic (4)  ·  Brain Diseases, Metabolic, Inborn (4)  ·  Central Nervous System Diseases (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Demyelinating Diseases (4)  ·  Endocrine System Diseases (4)  ·  Genetic Diseases, Inborn (4)  ·  Genetic Diseases, X-Linked (4)  ·  Hereditary Central Nervous System Demyelinating Diseases (4)  ·  Heredodegenerative Disorders, Nervous System (4)  ·  Intellectual Disability (4)  ·  Metabolic Diseases (4)

Sponsors

Children's Hospital of Philadelphia (2)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  Poxel SA (1)

Countries

United States (3)

Top investigators

Adeline Vanderver, MD (2)

Results publications

PMID 32342562, PMID 32749716

NIH funding

U01NS106845 (1), U54NS115052 (1)